3-iodobenzylguanidine has been researched along with Ataxia of Gait in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fujino, S; Higashi, K; Hirose, G; Hori, A; Kaito, M; Kakeshita, K; Kataoka, S; Miaki, M; Saiki, M; Saiki, S; Sakai, K; Taki, S | 1 |
1 other study(ies) available for 3-iodobenzylguanidine and Ataxia of Gait
Article | Year |
---|---|
Cardiac 123I-MIBG scintigraphy can assess the disease severity and phenotype of PD.
Topics: 3-Iodobenzylguanidine; Adult; Age of Onset; Aged; Aged, 80 and over; Analysis of Variance; Case-Control Studies; Enzyme Inhibitors; Female; Gait Ataxia; Heart; Humans; Iodine Radioisotopes; Lewy Body Disease; Male; Middle Aged; Multiple System Atrophy; Neurologic Examination; Parkinson Disease; Phenotype; Radionuclide Imaging; Regression Analysis; Severity of Illness Index; Statistics, Nonparametric; Tremor | 2004 |